PharmaResearch Co., Ltd. (KOSDAQ:214450)

PharmaResearch Revenue

PharmaResearch had revenue of 178.70B KRW in the quarter ending June 30, 2026, with 27.09% growth. This brings the company's total for the last twelve months to 603.58B, up 34.19% year-over-year. In the year 2025, PharmaResearch had annual revenue of 536.29B with 53.18% growth. That makes PharmaResearch the 11,738th largest company in the world by revenue and 563rd in South Korea.

• Revenue (ttm): 603.58B
• Revenue Growth: +34.19%
• P/S Ratio: 4.12
• Revenue / Employee: 1.10B
• Employees: 550
• Market Cap: 2.49T

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 328.79B 61.3%
• Overseas 207.50B 38.7%

Fiscal year ended Dec 31, 2025 See the full PharmaResearch breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	536.29B	186.17B	53.18%
Dec 31, 2024	350.12B	89.10B	34.14%
Dec 31, 2023	261.01B	66.25B	34.02%
Dec 31, 2022	194.76B	40.68B	26.40%
Dec 31, 2021	154.08B	45.34B	41.69%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error